215 related articles for article (PubMed ID: 15723309)
1. Fecal and urinary excretion of aflatoxin B1 metabolites (AFQ1, AFM1 and AFB-N7-guanine) in young Chinese males.
Mykkänen H; Zhu H; Salminen E; Juvonen RO; Ling W; Ma J; Polychronaki N; Kemiläinen H; Mykkänen O; Salminen S; El-Nezami H
Int J Cancer; 2005 Jul; 115(6):879-84. PubMed ID: 15723309
[TBL] [Abstract][Full Text] [Related]
2. Assessment of aflatoxin exposure using serum and urinary biomarkers in São Paulo, Brazil: A pilot study.
Jager AV; Tonin FG; Baptista GZ; Souto PC; Oliveira CA
Int J Hyg Environ Health; 2016 May; 219(3):294-300. PubMed ID: 26740158
[TBL] [Abstract][Full Text] [Related]
3. Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in The Gambia, West Africa.
Groopman JD; Hall AJ; Whittle H; Hudson GJ; Wogan GN; Montesano R; Wild CP
Cancer Epidemiol Biomarkers Prev; 1992; 1(3):221-7. PubMed ID: 1339082
[TBL] [Abstract][Full Text] [Related]
4. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4.
Gallagher EP; Kunze KL; Stapleton PL; Eaton DL
Toxicol Appl Pharmacol; 1996 Dec; 141(2):595-606. PubMed ID: 8975785
[TBL] [Abstract][Full Text] [Related]
5. Quantification and validation of enzyme immunoassay for urinary aflatoxin B1-N7-guanine adduct for biological monitoring of aflatoxins.
Nayak S; Sashidhar RB; Bhat RV
Analyst; 2001 Feb; 126(2):179-83. PubMed ID: 11235100
[TBL] [Abstract][Full Text] [Related]
6. Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi Autonomous Region, People's Republic of China.
Groopman JD; Zhu JQ; Donahue PR; Pikul A; Zhang LS; Chen JS; Wogan GN
Cancer Res; 1992 Jan; 52(1):45-52. PubMed ID: 1727385
[TBL] [Abstract][Full Text] [Related]
7. Molecular dosimetry in rat urine of aflatoxin-N7-guanine and other aflatoxin metabolites by multiple monoclonal antibody affinity chromatography and immunoaffinity/high performance liquid chromatography.
Groopman JD; Hasler JA; Trudel LJ; Pikul A; Donahue PR; Wogan GN
Cancer Res; 1992 Jan; 52(2):267-74. PubMed ID: 1728400
[TBL] [Abstract][Full Text] [Related]
8. Effects of multiple risk factors for hepatocellular carcinoma on formation of aflatoxin B1-DNA adducts.
Yu MW; Lien JP; Liaw YF; Chen CJ
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):613-9. PubMed ID: 8824363
[TBL] [Abstract][Full Text] [Related]
9. Biotransformation of aflatoxin B1 in rabbit lung and liver microsomes.
Daniels JM; Liu L; Stewart RK; Massey TE
Carcinogenesis; 1990 May; 11(5):823-7. PubMed ID: 2110514
[TBL] [Abstract][Full Text] [Related]
10. Modulation of aflatoxin B1 biotransformation in rabbit pulmonary and hepatic microsomes.
Daniels JM; Massey TE
Toxicology; 1992 Aug; 74(1):19-32. PubMed ID: 1514185
[TBL] [Abstract][Full Text] [Related]
11. Plasma antioxidant vitamins, chronic hepatitis B virus infection and urinary aflatoxin B1-DNA adducts in healthy males.
Yu MW; Chiang YC; Lien JP; Chen CJ
Carcinogenesis; 1997 Jun; 18(6):1189-94. PubMed ID: 9214602
[TBL] [Abstract][Full Text] [Related]
12. Identification of aflatoxin M1-N7-guanine in liver and urine of tree shrews and rats following administration of aflatoxin B1.
Egner PA; Yu X; Johnson JK; Nathasingh CK; Groopman JD; Kensler TW; Roebuck BD
Chem Res Toxicol; 2003 Sep; 16(9):1174-80. PubMed ID: 12971806
[TBL] [Abstract][Full Text] [Related]
13. Occurrence of aflatoxin M1 in urines from rural and urban adult cohorts in Bangladesh.
Ali N; Hossain K; Blaszkewicz M; Rahman M; Mohanto NC; Alim A; Degen GH
Arch Toxicol; 2016 Jul; 90(7):1749-55. PubMed ID: 26391179
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic and tumor suppressor pathways in subchronic aflatoxicosis in rats: Association with serum and urinary aflatoxin exposure biomarkers.
Apolinário LA; Ramalho LNZ; Moosavi MH; Jager AV; Augusto MJ; Trotta MR; Petta T; Khaneghah AM; Oliveira CAF; Ramalho FS
Food Chem Toxicol; 2021 Jul; 153():112263. PubMed ID: 34015426
[TBL] [Abstract][Full Text] [Related]
15. Intra-laboratory Development and Evaluation of a Quantitative Method for Measurement of Aflatoxins B1, M1 and Q1 in Animal Urine by High Performance Liquid Chromatography with Fluorescence Detection.
Du X; Schrunk DE; Shao D; Imerman PM; Wang C; Ensley SM; Rumbeiha WK
J Anal Toxicol; 2017 Oct; 41(8):698-707. PubMed ID: 28985321
[TBL] [Abstract][Full Text] [Related]
16. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1.
Gallagher EP; Wienkers LC; Stapleton PL; Kunze KL; Eaton DL
Cancer Res; 1994 Jan; 54(1):101-8. PubMed ID: 8261428
[TBL] [Abstract][Full Text] [Related]
17. Use of an improved method for analysis of urinary aflatoxin M1 in a survey of mainland China and Taiwan.
Cheng Z; Root M; Pan W; Chen J; Campbell TC
Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):523-9. PubMed ID: 9232340
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of modified yeast cell wall extracts to reduce aflatoxin B1 absorption in dairy ewes.
Firmin S; Morgavi DP; Yiannikouris A; Boudra H
J Dairy Sci; 2011 Nov; 94(11):5611-9. PubMed ID: 22032384
[TBL] [Abstract][Full Text] [Related]
19. Molecular epidemiology of aflatoxin exposures: validation of aflatoxin-N7-guanine levels in urine as a biomarker in experimental rat models and humans.
Groopman JD; Wild CP; Hasler J; Junshi C; Wogan GN; Kensler TW
Environ Health Perspect; 1993 Mar; 99():107-13. PubMed ID: 8319607
[TBL] [Abstract][Full Text] [Related]
20. Determination of aflatoxin biomarkers in excreta and ileal content of chickens.
Jurišić N; Schwartz-Zimmermann HE; Kunz-Vekiru E; Moll WD; Schweiger W; Fowler J; Berthiller F
Poult Sci; 2019 Nov; 98(11):5551-5561. PubMed ID: 31198963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
